Biological Technology in Pharmaceuticals - 14th Shanghai ...

ahemhootBiotechnology

Dec 5, 2012 (4 years and 6 months ago)

449 views


1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



1

/
14


Conference Program



Opening Ceremony & Keynote Speech

Venue: Auditorium, 3F

时间

演讲嘉宾

演讲题目

May 10

Opening Ceremony




Ke y n o t e
S p e e c h


C h a i r: R A O Z i h e

A M
9
:
4 5
-
1 0:1 5

L
uc

M
ONTAGNIER

N o b e l L a u r a n t
( P h y s i o l o g y o r Me d i c i n e, 2 0 0 8 ), P r e s i d e n t o f
Wo r l d F o u n d a t i o n f o r A I D S R e s e a r c h &
P r e v e n t i o n

H I V / A I D S : N e w P r o s p e c t s
f o r Di a g n o s i s a n d T r e a t me n t

A M
1 0:
15
-
1
0:4
5

William

W.
CHIN

E x e c u t i v e D e a n f o r
R e s e a r c h, B e r t a r e l l i P r o f e s s o r i n T r a n s l a t i o n a l
Me d i c i n e S c i e n c e a n d P r o f e s s o r o f Me d i c i n e,
H a r v a r d Me d i c a l S c h o o l ( HMS )

N u r t u r i n g I n t e r n a t i o n a l
C o l l a b o r a t i v e P a r t n e r s h i p s i n
T r a n s l a t i o n a l Me d i c i n e: Wh y,
Wh a t a n d H o w?"

A M 1 0:4 5
-
1 1:0 0

C o f f e e B r e a k

A M
1
1:0 0
-
1 1:3
0

S t e p h e n
H.
F
R I E N D

P r e s i d e n t a n d
co
-
Founder, Sage

Bionetworks

EU

The Marriage of
"Translational Medicine" to
"Big Data": Key
Opportunities to
C
hange
How we do Science

AM
11:3
0
-
12:00

Garry N
EIL

Corporate Vice President,
Corporate Office of Science & Technology,
Johnson & Johnson



S

1

剥杵污瑩R湳 慮a 䥮t
敲湡n楯湡i

䍯潰敲慴a潮

Venue

5A

Meeting Room

时间


演讲嘉宾

演讲题目


1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



2

/
14



S
2

乥w T散桮潬潧礠楮⁄i畧⁒♄

Venue

3H+I+J

Meeting Room

5

10


Session 1 Chair

Zhaokui WAN

S e n i o r C h i e f S c i e n t i s t o f P f i z e r, F o r me r
P r e s i d e n t ( 2 0 0 9
-
2 0 1 0 ) o f
C h i n e s e
-
A me r i c a n B i o m e d i c a l A s s o c i a t i o n ( C A B A )

P M
2
:
0
0
-
2:
3
0

Mi c h a e l R. Mc G u r
k


Ma n a g i n g P a r t n e r o f
C a mb r i d g e O f f i c e, F i n n e g a n H e n d e r s o n F a r a b o w
G a r r e n t D u n n e r/L L P

I d e n t i f y a n d
P
r o t e c t
I
n t e l l e c t u a l
P
r o p e r t y i n
P
h a r ma c e u t i c a l
P
r o c e s s
a n d
F
o r mu l a t i o n
I
n n o v a t i o n

P M
2:
3
0
-
3
:
0
0

S h a o y u C H E N



Ma n a g i n g D i r e c t o r, C h i n a
F o o d a n d Dr u g
P r a c t i c e
, C o v i n g t o n & B u r l i n g L L P,
B e i j i n g O f f i c e

R e g u l a t o r y a n d L e g a l
C o n s i d e r a t i o n s f o r P h a r ma c e u t i c a l
C o mp a n i e s t o S u c c e e d i n t h e U.S.
a n d C h i n a


P M
3
:
0
0
-
3:
3
0

Y i n P h i l i p
Z HA N G

Co
-
Managing Principal,
Milstein Zhang & Wu LLC

IP/Legal Aspects of Intern
ational
Biopharma R&D Collaborations

PM 3:30
-
3:50

Coffee Break

PM
3:50
-
4:20

Binhui N
I

H e a d a n d E x t e r n a l I n n o v a t i o n a n d
P a r t n e r i n g o f S a n o f i


S a n o f i:

A d i v e r s i f i e d
g l o b a l
h e a l t h c a r e l e a d e r
---
Creating Value
Through Partnership

PM 4:20
-
4:50

Tong Z
HANG

A s s o c i a t e o f N e w Y o r k O f f i c e,
F i s h & R i c h a r d s o n P.C.


T h e "
Am
erica Invents Act": What
Y
ou
N
eed to
K
now

PM 4:50
-
5:20

Wansheng Jerry L
IU

P a t e n t A t t o r n e y o f F o x
R o t h s c h i l d L L P

H o w S i mi l a r I s b i o s i mi l a r?
I n t r o d u c i n g t h e n e w e s t d r a f t
G u i d a n c e o n B i o s i mi l a r P r o d u c t
D e v e l o p me n t b y t h e U S F D A

P M 5:2 0
-
5:5 0

Ad
am

P
OWELL

P a r t n e r a n d P r e s i d e n t o f
P a y e r + P r o v i d e r

U n d e r s t a n d i n g A me r i c a n a n d
C h i n e s e H e a l t h c a r e S y s t e m
R e f o r m

时间

演讲嘉宾

演讲题目

5

1 0


S e s s i o n 2


Co
-
Chair:

Mingde XIA
,
Senior Director in Corporate Office of Science &
Technology, Johnson & Johnson

Co
-
Chair:
Min C
HEN
,
Senior Scientist of Novartis

PM 2:00
-
2:30




丹麦
投资促进局



1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



3

/
14





PM 2:30
-
3:00

Zheng J
IANG

A s s o c i a t e P r o f e s s o r, U n i v e r s i t y o f
Wa s h i n g t o n S c h o o l o f Me d i c i n e

Me t a b o l i c
A
c t i v a t i o n
-
b a s e d
P
r e d i c t i o n o f
T
o x i c i t y i n
D
r u g
D
e v e l o
p me n t

P M 3:0 0
-
3:3 0

J e a n W
ANG

S e n i o r P r i n c i p a l S c i e n t i s t, Me r c k & C o.,
I n c.

D r u g P r o d u c t D e v e l o
p me n t

C h a l l e n g e s a n d O p p o r t u n i t i e s:
I n t e g r a t e d A p p r o a c h o f N o v e l
F o r mu l a t i o n s T e c h n o l o g y

P M 3:3 0
-
3:5 0

C o f f e e B r e a k

P M 3:5 0
-
4:2 0

A l l e n R
E I T Z


C h i e f E x e c u t i v e O f f i c e r, P e n n s y l v a n i a
B i o t e c h n o l o g y C e n t e r, P e n n s y l v a n i a D r u g D i s c o v e r y
I n s t i t u t e

N e w A p p r o a c h e s f o r t h e T r e a t me n t
o f
Am
yotrophic Lateral Sclerosis

PM 4:20
-
4:50

Jong yuh C
HERNG

A s s o c i a t e P r o f e s s o r, D e p a r t me n t
o f C h e mi s t r y a n d B i o c h e mi s t r y, T a i w a n N a t i o n a l C h u n g
C h e n g U n i v e r s i t y

E n h a n c i n g a n d t a r g e t i n g g e n e
d e l i v e r y b y i n f l u e
n z a v i r u s

P M 4:5 0
-
5:2 0

Gu i q i
n g L
I A N G

I n v e s t i g a t o r I I I, N o v a r t i s I n s t i t u t e s
f o r B i o me d i c a l R e s e a r c h, I n c.

O p p o r t u n i t y o f P B P K Mo d e l i n g a n d
S i mu l a t i o n i n Dr u g D i s c o v e r y

P M 5:2 0
-
5:5 0

B i n S
HI

S e n i o r R e s e a r c h B i o l o g i s t o f Me r c k, U S A

C h a l l e n g e s a n d O p p o r t u n i t i e s i n t h e
D e v e l o p me n t

o f s i R N A L i p i d
N a n o p a r t i c l e s


1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



4

/
14



S
3

䙯F敦e潮琠䉩潬潧楣a氠T散h湯汯杹

Venue

5F
Meeting Room


时间

演讲嘉宾

演讲题目

5

10


分会主席:

1.
Brian R
UDKIN


Research Director, CNRS/ENS Lyon & ECNU




2.

C
UI

Jisong

VP, Head of Drug
Discovery and Translation, HUA
Medicine

PM 2:00
-
2:30

LIU Xinyuan

M e m b e r o f C A S & P r o f e s s o r,
I n s t i t u t e o f B i o c h e m i s t r y a n d C e l l B i o l o g y, S h a n g h a i
I n s t i t u t e s f o r B i o l o g i c a l S c i e n c e s, C A S


C a n c e r T a r g e t i n g

G e n e
-
V i r o
-
T h e r a p y

P M 2:3 0
-
3:0 0

B r i a n R
U D K I N


R e s e a r c h D i r e c t o r, C N R S/E N S
L y o n & E C N U



P e p t i d e
A
p
t a me r
s:
P
r e c i s i o n
T
o o l s
f o r
E
a r l y
D
e v e l o
p me n t

o f
N
o v e l
T
h e r a p e u t i c
C
o mp o u n d s

P M 3:0 0
-
3:3 0

S e r g e P
A MP F E R

D i r e c t o r o f B e l g i u m Wa l l o n i a
B i o t e c h C o a c h i n g

B u i l d i n g a
S
u c c e s s f u l
C
e l l
T
h e r a p y
I
n d u s t r y

P M
3:3 0
-
3:5 0

C o f f e e B r e a k

P M 3:5 0
-
4:2 0

Y u l i a S
I DOR OV A

P o s t d o c t o r, I n s t i t u t e o f
B i o t e c h n o l o g y, U n i v e r s i t y o f H e l s i n k i

S
ma l l
M
o l e c u l a r
W
e i g h t
A
r t e mi n
M
i me t i c f o r t h e
T
r e a t me n t o f
N
e u r o p a t h i c
P
a i n

P M 4:2 0
-
4:5 0

S t e v e n S
UN

P r e s i d e n t o f G e n e Wi z


P M 4:5 0
-
5:2 0

Me n g X
IA

C E O o f T r a n s g e n e
B i o p h a r ma c e u t i c a l

T e c h n o l o g y ( S h a n g h a i ) C o., L t d.


P M 5:2 0
-
5:5 0

R a p h a e l A
N A S T HA S E

E x p o r t Ma n a g e r o f
B i o T r a y



1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



5

/
14


S
4

T牡湳污瑩潮慬r䵥摩捩湥na湤 健牳潮慬楺敤 周敲慰a

5F, Yangtze River Hall




时间

演讲嘉宾

演讲题目

5

10



PM 2:00
-
3:30

Session 4 Panel I

Chair


David E. G
OLAN

P r o f e s s o r a n d D e a n f o r G r
a d u a t e E d u c a t i o
n
a n d
G l o b a l
E d u c a t i o n P r o g r a ms, H a r v a r d Me d i c a l S c h o o l

Wi l l i a m W. C
HI N


E x e c u t i v e D e a n f o r R e s e a r c h,
H a r v a r d Me d i c a l S c h o o l


L e e M. N
ADLER


Professor and Dean for Clinical
and Translational Research, Harvard Medical School


Stephen F
RIEND

P r e s i d e n t
,
Sage Bionetworks,
Former SVP of Merck and Head of Oncology


Winston Patrick K
UO
,
Director of

Harvard

Catalyst

Laboratory for Innovative
Translational

Technologies, Harvard Medical School


Jiping W
ANG

Associate Director of Hepatobilliary
Cancer Progr
am
, Division of Surgical Oncology at
Brigh and Women’s Hospital, Harvard Medical
School and the G
astrointestinal Cancer Treatment
Center at Dana
-
Farber Cancer Institute


Vincent L
OTTEAU


Co
-
Founder of the European
Institute on Systems Biology and Medicine, France



PM
4:00
-
5:30

Session 4 Panel II

Co
-
chair:

Dr. Yonghao Gui
Vice President of
Fudan
University, Dean of Fudan

University Shanghai Medical College

Co
-
chair:
Quoqiang Chen
Vice President of Jiaotong University,

Dean of
Jiaotong
University Medical School

Xuetao C
AO
,

Professor and President of

Chinese Academy of Medical Science


Yonghao G
UI
,
Vice President of Fudan University,
Dean of Fudan University Shanghai Medical College


Hongzhuan C
HEN

Professor and Vice Dean of
Jiaotong University Medical School


Yizhun Z
HU
,
Professor and Dean of Fudan
University School of Pharmacy



1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



6

/
14


时间

演讲嘉宾

演讲题目

5

11



AM
9:00
-
10:30

Session 4 Panel III

Co
-
chair:

Stephen F
RIEND

P r e s i d e n t, S a g e B i o n e t w o r k s, F o r me r S V P o f Me r c k
a n d H e a d o f O n c o l o g y

Co
-
chair:
Jason Gang J
IN
,

CEO of ShanghaiBio Corporation, EVP of Shanghai
Biochip

Jingwu Z
ANG


S e n i o r Vi c e P r e s i d e n t a n d H e a d o f
G S K R &D C h i n a

T r a n s l a t i o n a l Me d i c i n e
F
r o m a
P h a r ma P e r s p e c t i v e

B i n P
ENG

G l o b a l H e a d, O n c o l o g y T a n s l a t i o n a l
M e d i c i n e C h i n a



K e r r y B
L A N C H A R D

S e n i o r V i c e P r e s i d e n t a n d
H e a d, E l i L i l l y C h i n a D r u g
D e v e l o p m e n t
, C h i n a


B e i Z
H A N G

Vi c e P r e s i d e n t, a n d H e a d o f L i l l y
R &D C h i n a


J o h n L
U K

H e a d o f O n c o l o g y, R o c h e R &D C h i n a


S t e v e Y
ANG


Vice President and Head of
R&D,

Asia

and Emerging Markets,

AstraZeneca

R&D Innovation and Partnership
in China and Asia

Nicholas C. D
RACOPOLI


Vi c e P r e s i d e n t a n d
H e a d o f O n c o l o g y B i o m a r k e r s, J a n s s e n R e s e a r c h &
D e v e l o p m e n t
, U S A

B i o m a r k e r a n d
C
o m p a n i o n
D
i a g n o s t i c s
A
p p l i c a t i o n s i n
D
r u g
D
e v e l o p m e n t

A M
1 0:3 0
-
1 1:0 0

C o f f e e B r e a k

A M
1 1:0 0
-
1 2:3 0

主席:
S e a n Z
H A N G


Me d i c a l D i r e c t o r a n d l i a i s o n
t o B MS C h i n a R &D a t
D i s c o v e r y, S A PA
-
G P E l e c t
-
P r e s i d e n t

Gu o q i n g C
AO


V P a n d G l o b a l H e a d o f
D i s c o v e r y, H e n g r u i P h a r m a c e u t i c a l G l o b a l R & D

T r a n s l a t i o n M e d i c i n e f o r
H e n g r u i P h a r m a c e u t i c a l: f r o m
B
e n c h t o
B
e d s i d e

P e n g W
ANG

C S O o f S i mc e r e P h a r ma c e u t i c a l


J o h n V. O
Y L E R

C E O o f B e i Ge n e


Yu e W
ANG

P I o f R &D,

H e a d o f Q u a n t i t a t i v e
B i o l o g y,

B e i G e n e


A M
1 2:3 0
-

L u n c h e o n D i s c u s s i o n


1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



7

/
14


PM
2:00

Host
:

Fenglin Life Science Park

Chair
:

Sophia Q
IAN
,
Managing Director, Fenglin Life Science Park office

PM
2:00
-
3:30

Co
-
Chair
:
Wen
g
ru S
ONG
, Head of Regional Oncology Develo
pm
ent/Takeda Shanghai
Develo
pm
ent Center &Millennium: Takeda Oncology Company, USA

Co
-
Chair
:
Mao M
AO
, Research Fellow, Pfizer Worldwide Research and Develo
pm
ent,
USA

David A F
LOCKHART
, Chair of
Indiana Institute for
Personalized Medicine, Chair of Cancer Genomics and
Professor of Medicine, Medical Genetics and
Pharmacology, Director of Clinical Pharmacology,
Indiana University School of Medicine in Indianapolis,
USA


Wenru S
ONG
, Head of Regional Oncology
Development
/Takeda Shanghai

Development

Center
&Millennium‘
Takeda Oncology Company, USA


Mao M
AO

, Research Fellow, Pfizer Worldwide
Research and
Development
, USA

Development of a
Quantitative Multiplex
assay to Detect ALK Fu
sion
Transcript in Lung Cancer

Huichuan S
UN

, Professor of Zhongshan Hospital Liver
Cancer Institute, Fudan University

P
ersonalized
T
reatment for
H
epatocellular
C
arcinoma

Yidong C
HEN
, Professor, Department of Epidemiology
and Biostatistics, The University of Texas Health Science
Center at San Antonio

Next
-
generation
S
equencing
T
echniques
R
eveal
I
nsights
of
D
ifferential
D
rug
S
ensitivity of
T
umor
C
ells

PM
3:30
-
4:00

Coffee Break

PM
4:00


5:30

Co
-
chair:

Jason Gang J
IN
, CEO of Shanghai Bio Corporation

Co
-
chair:

Harry Y
ANG
, CBA

Kelly H
ONG
, General Manager of Affymetrix China


Yingshuang C
HAI
, National Sales Leader, Clinical, East
China Sr.District Manager

Molecular Cell Biology,
Applied Biosystems, Part of Life Technologies


Hong X
IE
, General Manager, Sequenom China


Jason Gang J
IN
, CEO of ShanghaiBio Corporation


Hongyue S
UN
, VP of Operation Technology Platform,
COO of Wuxi Genomic Center, Wuxi AppTec


Peter Y
AN
,
Technical Progr/Project Manager at
Frederick National Laboratory for Cancer Research,
NCI/NIH, USA



1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



8

/
14


S
5

䍬楮楣 剥R敡e捨c慮a 䑥癥汯灭敮l

Venue

3E

Meeting Room





时间

演讲嘉宾

演讲题目

5

1
0


Co
-
chair:

Zhiliang W
U

Head of the Translational Neuroscience, Center for
Applied
Genomics, Children’
s Hospital of Philadelphia Research Institute

PM 2:00
-
2:30

Marcia L
EVENSTEIN


V P, S t a t i s t i c s H e a d f o r
t h e S p e c i a l t y C a r e B U, P f i z e r, I n c.

C h a l l e n g e s a n d O p p o r t u n i t i e s i n
D r u g D e v e l o
p m
e n t f o r R a r e
D i s e a s e s


P M 2:3 0
-
3:0 0

Z h i l i a n g W
U


H e a d o f t h e T r a n s l a t i o n a l
N e u r o s c i e n c e, C e n t e r f o r Ap p l i e d G e n o mi c s,
C h i l d r e n ’
s H o s p i t a l o f P h i l a d e l p h i a R e s e a r c h I n s t i t u t e

N e w P a r a d i g m o f G e n o mi c s
G u i d e d C l i n i c a l T r i a l s t o D e v e l o p
T a r g e t e d T h e r a p y: A C a s e S t u d y
w i t h A t t e n t i o n D e f i c i t a n d
H y p e r a c t i v i t y

P M 3:0 0
-
3:3 0

E mma n u e l l e VOI S I N

C E O o f V o i s i n L i f e
S c i e n c e s C o n s u l t i n g

H o t

T
o p i c s i n C l i n i c a l
D
e v e l o p me n t i n E u r o p e

P M 3:3 0
-
3:5 0

C o f f e e B r e a k

P M 3:5 0
-
4:2 0

L i X
I N G

S e n i o r P r i n c i p a l S c i e n t i s t o f P f i z e r, I n c.

D i s c o v e r y o f
P
r
o t e
i
n,
S
e l e c t i v e a n d
E
f f i c a c i o u s p 3 8 MA R K I n h i b i t o r
as
C
linical
D
rug
C
andidate

PM 4:20
-
4:50

Xiuli ZHAO

O f f i c e Di r e c t o r, V i c e D i r e c t o r o f t h e
N a t i o n a l Me d i c i n e C l i n i c a l T r i a l C e n t e r, B e i j i n g
T o n g r e n H o s p i t a l o f C a p i t a l Me d i c a l U n i v e r s i t y

Ma n a g e me n t O f D r u g C l i n i
c a l T r i a l
I n Me d i c a l I n s t i t u t i o n

P M 4:5 0
-
5:2 0

Ha i b o W
U

CEO of Giant Med
-
pharma Services,
Inc.

The Role of CRO In Difference
Stage of Clinical Trials


1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



9

/
14



S
6

乥w T散桮潬潧礠楮i偨慲P慣a畴楣u氠偲o捥c猠慮s
乥w 䥮摵獴物慬 䉩潬潧楣a氠T散h湯汯杹

Venue

5F

Meeting Room

时间


演讲嘉宾

演讲题目

5

11


Session 6 Chair:

AM
9
:
00
-
9
:
3
0

Martin HAMPEL


L a b He a d

An a l y t i c s & Dr u g
De l i v e r y S u p p o r t

, P r o t e i n S c i e n c e, B o e h r i n g e r
I n g e l h e i m P h a r ma G mb H & C o. K G

Op t i mi z i n g P r o c e s s e s a n d P r o c e s s
De v e l o p me n t wi t h Hi g h
T h r o u g h p u t

S c r e e n i n g a n d
An a l y t i c a l T o o l s

AM
9:3 0
-
1 0:0 0

Z h a n g l i n L
IN

P r o f e s s o r o f D e p a r t m e n t o f
C h e m i c a l E n g i n e e r i n g; A s s o c i a t e D i r e c t o r o f
n a t i o n a l E n g i n e e r i n g L a b f o r I n d u s t r i a l E n z y m e s,
T s i n g h u a U n i v e r s i t y

R e c o m b i n a n t
P
r o d u c t i o n o f
P
e p t i d e s i n E s c h e r i c h i a
C
o l i
U
s i n g
C
l e a v a b l e
S
e l f
-
a g g r e g a t i n g
T
a g
( c S A T )

A M
1 0:0 0
-
1 0:3 0

L i q i a n g D e r e k T
OU

Research Scientist of
Taketa
-
Millennium Pharmaceuticals

An
I
nnovative
R
oom
T
emperature
S
terilization
E
qui
pm
ent for Chinese
M
arket

AM 10:30
-
10:45

Coffee Break

AM
10:45
-
11:15

Guiming LIU

Di v i s i o n Di r e c t o r, C h e mi s t r y
E x a mi n a t i o n De p a r t me n t, S t a t e I n t e l l e c t u a l
P r o p e r t y Of f i c e o f P R C

B i o me d i c a l N a t u r a l P o l y s a c c h a r i d e s
P a t e n t A n a l y s i s P r o j e c t R e p o r t

A M
1 1:1 5
-
1 1:4 5

L i j u n W
ANG

A s s o c i a t e P r i n c i p a l S c i e n t i s t,
G l o b a l P r o c u r e m e n t
D e p a r t m e n t, M e r c k

A C o s t
-
E f f e c t i v e M e t h o d t o
R e m o v e P a l l a d i u m f r o m
P h a r m a c e u t i c a l I n t e r m e d i a t e s a n d
A P I s





1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



10

/
14



S
7

䉩潬潧楣慬 T散桮潬潧礠楮i偨慲浡P敵瑩捡cs

(P䅒T 䤩

Venue


3C+3D

Meeting Room

时间

演讲嘉宾

演讲题目

5

11


Session 7 Part I

Chair:
Zhihong C
HEN

Principal Scientist of Eisai Inc. USA, President (2011
-
2012)
of CABA

AM 9:00
-
9:30

Zhiyong Q
IU

P r o j e c t L e a d,
B
i o mo l e c u l e s,
Ma n n K i n d C o r p o r a t i o n

Q u e s t f o r
D
u r a b l e
D
i s e a s e
C
o n t r o l b y
I
n d u c t i o n o f
O
p t i ma l
E
f f e c t T c e l l s i n
C
a n c e r
P
a t i e n t s

A M 9:3 0
-
1 0:0 0

Ra
man

R
AO

H e a d o f E x t e r n a l R &D,
S a n o f i P a s t e u r

E x t e r n a l P a r t n e r s h i p s a n d I n t e r n a l
d i s c o v e r y f o r s u c c e s s f u l V a c c i n e
D e v e l o p me n t

A M 1 0:0 0
-
1 0:3 0

Y i h a n WA N G


A s s o c i a t e D i r e c t o r o f
A R I A D P h a r ma c e u t i c a l s, I n c.

R e c e n t A d v a n c e s i n T a r g e t e d T h e r a p y
f o r O n c o l o g y

A M 1 0:3 0
-
1 0:4 5

C o f f e e B r e a k

A M 1 0:4 5
-
1 1:1 5

L a u r a H
ON G

S e n i o r R e s e a r c h S c i e n t i s t,
MS D ( U S A )

C h a l l e n g e s a n d S o l u t i o n s f o r
Ma i n t a i n i n g Q u a l i t y a n d P o t e n c y o f
t h e P r o d u c t i n V a c c i n e D e v e l o p me n t

A M 1 1:1 5
-
1 1:4 5

C e d r i c Y. S
Z P I R E R

C E O & c o
-
F o u n d e r o f
D e l p h i
G e n e t i c s S A

U s e o f
B
a c t e r i a l
S
e l e c t i o n
G
e n e s t o
G
e t
H
i g h e r
Y
i e l d s a n d t o
R
e mo v e
A
n t i b i o t i c
R
e s i s t a n c e
G
e n e s i n
B
i o p r o d u c t i o n s





1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



11

/
14



S
7

䉩潬潧楣慬 T散桮潬潧礠楮i偨慲浡P敵瑩捡cs

(P䅒T 䤩

Venue


3C+3D

Meeting Room

时间


演讲嘉宾

演讲题目

5

11


Session 7 Part II:

Zhiyong Q
IU

P r o j e c t L e a d,
B
i o mo l e c u l e s, Ma n n K i n d C o r p o r a t i o n

P M 2:0 0
-
2:3 0

A n n a C h e r o u v r i e r H
A N S S ON


H e a d o f
B u s i n e s s
D e v e l o p me n t

L i f e S c i e n c e, I n v e s t i n
S k å n e

I n t r o d u c i n g
C
a n c e r
R
e s e a r c h
E
x c e l l e n c e i n S o u t h e r n S we d e n

D a n M
OGR E N


B u s i n e s s
D e v e l o p me n t

D i r e c t o r, L u n d L i f e S c i e n c e I n c u b a t o r

U l r i k a R
I N GD A HL


C h i e f C o mmu n i c a t i o n
O f f i c e r

L a r s
-
E r i k E
R I KS S ON


C h i e f E x e c u t i v e O f f i c e r,
C l i n i c a l L a s e r T h e r mi a

P M 2:3 0
-
3:0 0

Ka r o l i n a Ö
S T E R L U N D

M a n a g e r F i e l d
A p p l i c a t i o n S c i e n t i s t E U a n d A s i a, G y r o s A B,
U p p s a l a, S w e d e n

A u t o m a t e d N a n o l i t e r S c a l e d
I m m u n o a s s a y P e r f o r m e d o n a
C o m p a c t D i s c: M a x i m i z i n g
P
r o d u c t i v i t y a n d
E
f f i c i e n c y i n
P
r o t e i n
B
i o a n a l y t i c s

P M 3:0 0
-
3:3 0

S a n j a y D. K
H A R E

C E O & P r e s i d e n t o f
I mmu n G e n e, I n c.

E mp o w e r e d
C
y t o k i n e
F
u s e d
-
a n t i b o d i e s t o
O
v e r c o me
L
i mi t a t i o n s o f
F
i r s t a n d
S
e c o n d
G
e n e r a t i o n
T
h e r a p e u t i c
A
n t i b o d i e s

P M 3:3 0
-
3:5 0

C o f f e e B r e a k

P M 3:5 0
-
4:2 0

Wi l l i
a m

C
AO

P r e s i d e n t, C h i n a B i o t e c h G r o u p
L t d

P a t i e n t
-
S p e c i f i c C a n c e r
I mmu n o t h e r a p y

P M 4:2 0
-
4:5 0

F e n g L
I


V i c e P r e s i d e n t o f G e n e r o n

T u r n i n g t h e
G
l o b a l
P
h a r ma c e u t i c a l
I
n d u s t r y
C
h a l l e n g e s i n t o
D
e v e l o p me n t
O
p p o r t u n i t i e s t o
G
r o w C h i n a B i o t e c h
B
u s i n e s s e s


t h e
C
a s e f o r G e n e r o n


1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



12

/
14


S
8

䉩B
-
䵡M步r 慮a 䑩慧湯D瑩t T散桮潬潧y

Venue


3E

Meeting Room

时间


演讲嘉宾

演讲题目

5

11


Session 8 Chair:

David W
ONG

A s s o c i a t e D e a n o f R e s e a r c h, t h e F e l i x & mi l d r e d Y i p
E n d o w e d P r o f e s s o r, U C L A S c h o o l o f D e n t i s t r y

A M 9:0 0
-
9:3 0

C a r l A.K. B
OR R E B A E C K


P r o g r a m
D i r e c t o r o f T h e S t r a t e g i c C e n t e r f o r
T r a n s l a t i o n a l C a n c e r R e s e a r c h C R E AT E H e a l t h,
D e p u t y Vi c e C h a n c e l l o r, C h a i r ma n
o f t h e
D e p a r t me n t o f I mmu n o t e c h n o l o g y, L u n d
U n i v e r s i t y

Mo l e c u l a r
P
o r t r a i t s
A
s s o c i a t e d w i t h
I
mp r o v e d
P
r o g n o s i s a n d

D
i a g n o s i s o f
C
a n c e r

A M 9:3 0
-
1 0:0 0

D a v i d W
ON G

A s s o c i a t e D e a n o f R e s e a r c h,
t h e F e l i x & mi l d r e d Yi p E n d o w e d P r o f e s s o r,
U C L A S c h o o l o f
D e n t i s t r y

S a l i v a: T h e E me r g i n g D i a g n o s t i c
F r o n t i e r

A M 1 0:0 0
-
1 0:3 0

D a v i d e B
E D OGN E T T I

A s s o c i a t e D i r e c t o r,
N I H C l i n i c a l C e n t e r F O C I S C e n t e r o f
E x c e l l e n c e


F e l l o w, I n f e c t i o u s Di s e a s e a n d
I mmu n o g e n e t i c s S e c t i o n, US N a t i o n a l I n s t i t u t e s
o f H e a l t h


F e d e r a t i o n o f C l i n i c a l I mmu n o l o g y
S o c i e t i e s ( F O C I S )

B i o ma r k e r s o f
I
mmu n o r e s p o n s i v e n e s s
i n
C
a n c e r
I
mmu n o t h e r a p y:
H
y p o t h e s i s
-
d r i v e n a n d
D
i s c o v e r y
-
d r i v e n
T
r a n s l a t i o n a l
A
p p r o a c h e s

A M 1 0:3 0
-
1 0:4 5

C o f f e e B r e a k

A M 1 0:4 5
-
1 1:1 5

J
o h n G
U

F o u n d e r & P r e s i d e n t o f
R e n a s c i o u s
C o r p o r a t i o n


A M 1 1:1 5
-
1 1:4 5

L a u r e n t B
UF F A T
/P i e r r e
-
E mma n u e l J OU V E

1. P r e s i d e n t, C E O a n d c o
-
f o u n d e r, A l t r a B i o;
2. C T O

A
l t r a
B
io



I
ntegrative Analysis of Life
Science Data

AM 11:45
-
12:15

Yuxun W
ANG

A s s o c i a t e D i r e c t o r, R &D,
Me t a ma r k
G e n e t i c s, I n c.

I n t e g r a t e
O
n c o g e n o mi c s
B
a s e d
A
n t i
-
c a n c e r
D
r u g
T
a r g e t a n d
B
i o ma r k e r






1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



13

/
14



S
9

偨慲浡Pe畴楣慬猠慮s 乡No
-
䉩潴B捨

Venue


5
F

Meeting Room

时间


演讲嘉宾

演讲题目

5

11


Session 9

Co
-
chair:

Achim G
Ö
PFERICH


Chair of Parmaceutical Technology Department,
University of Regensburg, Germany

Co
-
chair:
W
U

Yusheng

P r e s i d e n t o f T e t r a n o v I n t e r n a t i o n a l, I n c. ( U S ) & T e t r a n o v
B i o p h a r m L L C ( C h i n a )

P M 2:0 0
-
2:3 0

A c h i m G
Ö
P F E R I C H

C h a i r o f P a r ma c e u t i c a l
T e c h n o l o g y D e p a r t me n t, U n i v e r s i t y o f R e g e n s b u r g,
G e r ma n y

N a n o p a r t i c l e I n t e r a c t i o n s wi t h C e l l
S u r f a c e R e c e p t o r s: N e w K e y s f o r
O l d l o c k s

P M 2:3 0
-
3:0 0

S h o u f e n g L
I

Di r e c t o r a n d T e c h n i c a l P r o j e c t
L e a d e r o f N o v a r t i s P h a r ma c e u t i c a l s C o r p o r a t i o n

R e c e n t
A
d v a n c e s i n P h a r ma c e u t i c s,
B i o p h a r ma c e u t i c s a n d P h y s i o l o g y
P h a r ma c e u t i c s

P M 3:0 0
-
3:3 0

Mi c h a e l F. H
ALLER

S e n i o r V i c e P r e s i d e n t o f
S t r a t e g i c P a r t n e r s h i p s o f An a p h o r e I n c.


D i f f e r e n t i a t i n g B i o s i mi l a r s t h r o u g h
D r u g D e l i v e r y

P M 3:3 0
-
3:5 0

C o f f e e B r e a k

P M 3:5 0
-
4:2 0

J e r r y Z
HA N G

S e n i o r T e c h n o l o g y D e v e l o p me n t
E n g i n e e r I I o f S h i r e H u ma n G e n e t i c T h e r a p i e s

L i p i d B a s e d T h e r a p e u t
i c
N a n o p a r t i c l e s

P M 4:2 0
-
4:5 0







1
4
届上海国际生物技术与医药研讨会

BIO
-
FORUM ㈰1
2

㈰2
2

5

9
-



中国·上海



14

/
14


S
10

乥w Ty灥 䵥t敲敤
-
摯d攠I湨慬ar ☠T散桮潬潧o

Venue

3E

Meeting Room

时间


演讲嘉宾

演讲题目

5

11


主席:

PM 2:00
-
2:30

B
AI

Chunxue
,

Chairman, Shanghai Respiratory
Research Institute
,
Chairman, Respiratory
Research Institute,
Zhongshan Hospital of
Fudan
University

Aerosol Inhalation Therapy for
Respiratory Disease Patients

PM 2:30
-
3:00

S
ONG

Yuanlin

V
ice
Chairman, Shanghai
Respiratory Research Institute
, V
ice
Chairman,
Respiratory Research Institute,
Zhongshan
Hospital of
Fudan University

Development of Aerosol Inhalation
Therapy

PM 3:00
-
3:30

中国医药工业研究总院


PM 3:30
-
4:00


(药厂
,待定